SMi's 1st Highly Potent Active Pharmaceutical Ingredients 2017

A session at SMi's 1st Highly Potent Active Pharmaceutical Ingredients 2017

In recent years there has been an emerging trend in the global market for Highly Potent Active Pharmaceutical Ingredients, which is largely driven by its major use in oncology for cancer treatment and more often in the form of anti-drug conjugates (ADCs).

With this continued development, SMi has been receptive to the steadily increasing market growth and have launched its first Highly Potent Active Pharmaceutical Ingredients conference, set to take place 22nd – 23rd May in London, UK.

The conference programme has been produced to enable delegates to gain knowledgeable insight on how to develop highly potent APIs more efficiently, safely and more cost effectively than before. Whether your area of expertise is in process development, scale up, occupational safety or outsourcing, this two day conference is certain to equip you with a wealth of actionable insights.

Alessandro Brigo, Toxicology Project Leader, Pharmaceutical Sciences
Andreas Flueckiger, Chief Occupational Health Officer, Roche
Gwydion Churchill, Associate Director of Chemistry, Antibiotics Business Unit, AstraZeneca
Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Hungary
Jack Brown, Senior Principal Scientist, Boehringer Ingelheim
James Evans, Vice President CMC, NuCana BioMed
Jason Hamm, Director of Chemical Development Operations, Bristol-Myers Squibb
Richard Denk, Head Sales Containment, SKAN AG

Address the challenges of working with HPAPIs and approaches to scale-up
Discuss strategies for CMO selection and solutions to better communication and transfer
Hear about Teva API’s Operational Excellence and QC Lab Transformation
Gain insight into the ISPE contamination Manual covering containment issues from the PDE/ OEL to life cycle
Learn about Health Hazard Assessment Classifications and the toxicological criteria of potent compounds

Inquiries: https://go.evvnt.com/80100-1

Register by 31 Jan: GBP 1099
Register by 28 Feb: GBP 1299
Register by 31 Mar: GBP 1399
Standard Price: GBP 1499

Speakers: Pharmaceutical Sciences, Roche, AstraZeneca, Gedeon Richter Hungary, Boehringer Ingelheim, NuCana BioMed, Bristol-Myers Squibb, SKAN AG and many more!

Sign in to add slides, notes or videos to this session

Tell your friends!


Date Mon 22nd May 2017

Short URL


Official event site


View the schedule


See something wrong?

Report an issue with this session